Dynavax Technologies | Credores Comerciais



Trade Creditors Alterar Data
AbbVie 2.94B 2.66B 2024-12
Adma Biologics USD 20.22M 4.2M 2024-12
Amgen USD 18.03B 15.63B 2025-06
AstraZeneca 23.99B 1.44B 2025-06
Biogen USD 408.4M 16.9M 2025-06
BioMarin Pharmaceutical 684.25M 390.5M 2025-06
Bristol-Myers Squibb USD 5.43B 1.42B 2025-06
Dynavax Technologies USD 2.7M 1.63M 2025-06
Gilead Sciences USD 582M 155M 2025-06
Glaxosmithkline 3.46B 10.01B 2024-12
Merck USD 4.04B 261M 2025-06
Neurocrine Biosciences 104.6M 5.4M 2025-06
Novartis USD 4.51B 245M 2025-06
Pfizer USD 5.17B 74M 2025-06
Regeneron Pharmaceuticals USD 723.9M 18.4M 2025-06
Roche Holding 4.35B 828M 2024-12
Sarepta Therapeutics USD 136.7M 19.4M 2025-06
TG Therapeutics 134.02M 92.06M 2025-06
Vertex Pharmaceuticals USD 3.71B 3.27B 2025-06


Dynavax Technologies Credores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.